Ipamorelin vs Lanreotide
Overview
Ipamorelin is primarily a performance & growth peptide, while Lanreotide is used for hormonal.
This page compares Ipamorelin and Lanreotide across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| Ipamorelin | Lanreotide | |
|---|---|---|
| Category | Performance & Growth | Hormonal |
| Regulatory status (US) | Research use only | FDA approved |
| Typical dosage | 200-300 mcg | 60-120 mg |
| Frequency | twice-daily | every 4 weeks |
| Reported benefits | Natural GH release, improved body composition, better sleep, anti-aging effects, no appetite increase | suppression of excess growth hormone and IGF-1 in acromegaly, improved progression-free survival in GEP-NETs, reduction of carcinoid syndrome symptoms, inhibition of multiple GI and pancreatic hormones |
| Reported side effects | Very well-tolerated. Rare: headache, injection site reactions | diarrhea, cholelithiasis, abdominal pain, hyperglycemia, bradycardia, injection site reactions, nausea, hypertension, headache, thyroid function decreases |
Key differences
Primary use. Ipamorelin is categorised under Performance & Growth, while Lanreotide falls under Hormonal. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.
Regulatory status. Ipamorelin: not FDA-approved; treated as a research compound. Lanreotide: FDA-approved.
Dosing. Ipamorelin is typically dosed at 200-300 mcg (twice-daily). Lanreotide is typically dosed at 60-120 mg (every 4 weeks).
Can you stack them?
Some protocols combine peptides, but stacking Ipamorelin and Lanreotide has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between Ipamorelin and Lanreotide?
- Ipamorelin is primarily a performance & growth peptide, while Lanreotide is used for hormonal. Ipamorelin is not FDA-approved; generally classified as a research compound, whereas Lanreotide is FDA-approved for one or more indications.
- What is Ipamorelin used for?
- GH secretagogue, anti-aging.
- What is Lanreotide used for?
- FDA-approved long-acting somatostatin analog for acromegaly, GEP-NETs, and carcinoid syndrome.
- Can you take Ipamorelin and Lanreotide together?
- Some users combine peptides within a single protocol, but stacking Ipamorelin and Lanreotide has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is Ipamorelin or Lanreotide FDA-approved?
- Ipamorelin is not FDA-approved; generally classified as a research compound. Lanreotide is FDA-approved for one or more indications.
Read the full articles
- Ipamorelin — full monograph: mechanism, research, dosing & references
- Lanreotide — full monograph: mechanism, research, dosing & references